MAMC Journal of Medical Sciences

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 7  |  Issue : 2  |  Page : 109--114

Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19: A Randomized Controlled Trial


Romit Saxena1, Muthu Rajanagam1, Urmila Jhamb1, Vikas Manchanda2, Sonal Saxena2, Pallavi1 
1 Department of Pediatrics, Maulana Azad Medical College and Associated LNJP Hospital, New Delhi, India
2 Department of Microbiology, Maulana Azad Medical College and Associated LNJP Hospital, New Delhi, India

Correspondence Address:
Dr. Romit Saxena
Department of Pediatrics, Maulana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi 110002
India

Background: Coronavirus disease 2019 (COVID-19) pandemic mounts an ever increasing challenge on healthcare resources. Ivermectin shows promise in in vitro studies on coronavirus, but there are few prospective trials on currently approved dosage recommendation for the treatment of COVID-19. Aims: To study the virologic and clinical recovery after single-dose ivermectin, given within first 5 days of symptom onset. Settings and design: Prospective, open-labeled, randomized controlled trial. Patients were recruited in between August 30, 2020, and November 6, 2020, at a single referral center for patients with COVID. Materials and methods: The study participants included patients presenting with severe acute respiratory syndrome coronavirus 2 infection. The patients were randomized to receive a single-dose ivermectin, 0.2 mg/kg in the treatment group (TG). Both groups [TG and control group (CG)], continued to receive standard treatment. Results: The recruited cohort was comparable in the two arms of the study, except age and height. There was no statistically significant difference in virologic clearance between the two arms (percentage COVID positive day 7: TG: 34.2% vs. CG: 52.6%, P = 0.165). Conclusion: Our study shows that after administration of single dose of currently approved doses of ivermectin (0.2 mg/kg), there does not exist a significant virologic or clinical recovery in COVID-19 disease.


How to cite this article:
Saxena R, Rajanagam M, Jhamb U, Manchanda V, Saxena S, Pallavi. Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19: A Randomized Controlled Trial.MAMC J Med Sci 2021;7:109-114


How to cite this URL:
Saxena R, Rajanagam M, Jhamb U, Manchanda V, Saxena S, Pallavi. Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19: A Randomized Controlled Trial. MAMC J Med Sci [serial online] 2021 [cited 2021 Dec 6 ];7:109-114
Available from: https://www.mamcjms.in/article.asp?issn=2394-7438;year=2021;volume=7;issue=2;spage=109;epage=114;aulast=Saxena;type=0